home.aspx
home.aspx
 
EVENTS

International Forum on Quality and Safety in Healthcare
INTERNATIONAL FORUM ON QUALITY AND SAFETY IN HEALTHCARE
July 17-17, 2019
All organisations whatever sector need to change and adapt.
Yet successfully delivering change can be challenging.
If you’re to get better at leading and managing change this workshop is for you.

2nd International Conference on Obesity and Chronic Diseases
2ND INTERNATIONAL CONFERENCE ON OBESITY AND CHRONIC DISEASES
July 18-19, 2019
ME Conferences extends warm welcome to International Conference on Obesity and Chronic Disease on March 11-12, 2019 Bali, Indonesia with a theme “Novel Therapeutics and Dietary Management for Obesity & Chronic Diseases”. Participating at Chronic Obesity 2019 will provide with an exce...

Anadolu Medical Center


Anadolu Medical Center is sheltered by the Anadolu Foundation and it is characterized by two major aspects : its non-profit status and its unique affiliation with the world praised Johns Hopkins Medicine. Dedication to health and wellness has been a top priority since the begining, when the two prominent families, Yazıcı and Özilhan established the Anadolu Foundation in 1979.

RELATED NEWS


DePuy Orthopaedics, Inc., part of the DePuy Synthes Companies of Johnson & Johnson, announced today that it has acquired privately-held BioMedical Enterprises, Inc. (BME), a leading manufacturer of Nitinol orthopaedic implants for small bone fixation. The implants are used to treat bunions, hammertoes and other foot and ankle deformities, as well as hand and wrist deformities. The BME acquisition reinforces Johnson & Johnson Medical Device's focus on accelerating meaningful innovatio...
DEPUYSYNTHES
READ MORE

BIAL announces today that the European Medicines Agency (EMA) has accepted Bial's application to review recent clinical trial data for Zebinix® (eslicarbazepine acetate) for its use as a once-daily monotherapy in the treatment of adult patients with newly diagnosed partial-onset (focal) epilepsy. Partial-onset seizures, also known as focal, are the most common type and are therefore an important first target for treatment.[1] Zebinix®, (eslicarbazepine acetate) is currently indicated in Europe a...
PRNEWSWIRE
READ MORE

Mango fruit is rich in pre-biotic dietary fiber, vitamins, minerals, and poly-phenolic flavonoid antioxidant compounds. According to new research study, mango fruit has been found to protect against colon, breast, leukaemia and prostate cancers. Several trial studies suggest that polyphenolic anti-oxidant compounds in mango are known to offer protection against breast and colon cancers......
THENATIONONLINENG
READ MORE

Two federal investigations - one examining opioid sales, another about a multiple sclerosis drug whose price had soared to $34,000 a vial - were only part of the troubles Mallinckrodt faced as the year began. The stock of the drugmaker, whose United States headquarters are in St. Louis, was tanking. Wall Street worried that Medicare might reduce the half-billion dollars it was spending yearly on a Mallinckrodt drug with limited evidence of effectiveness. This year, the company left the industry ...
MEDCITY NEWS
READ MORE

On Thursday 12 May, South Africans heard that millions of children in their formative years – about 63% of the country’s youngest – were living in poverty affecting their physical, cognitive and emotional development. The report was The South African Early Childhood Review, a first-of-its-kind annual publication providing data, analysis and commentary on more than 40 statistical indicators measuring the progress of Early Childhood Development (ECD) service delivery. The measures spanned multiple...
DAILYMAVERICK
READ MORE

According to the latest SEC Filings, institutions owning shares of Sabra Health Care REIT, Inc. of the Financial sector have increased their positions by 0.30% over the past 3 months. Institutions now own 98.30% of the company....
ENGELWOODDAILY
READ MORE

EVENTS

International Forum on Quality and Safety in Healthcare
INTERNATIONAL FORUM ON QUALITY AND SAFETY IN HEALTHCARE
July 17-17, 2019
All organisations whatever sector need to change and adapt.
Yet successfully delivering change can be challenging.
If you’re to get better at leading and managing change this workshop is for you.

2nd International Conference on Obesity and Chronic Diseases
2ND INTERNATIONAL CONFERENCE ON OBESITY AND CHRONIC DISEASES
July 18-19, 2019
ME Conferences extends warm welcome to International Conference on Obesity and Chronic Disease on March 11-12, 2019 Bali, Indonesia with a theme “Novel Therapeutics and Dietary Management for Obesity & Chronic Diseases”. Participating at Chronic Obesity 2019 will provide with an exce...